Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07642531

A Modular Cloud Platform For Fertility Preservation

The research was designed as a randomized controlled study to determine the effectiveness of a modular cloud-based training platform in increasing awareness of fertility preservation.

The study aims to develop a free, modular, cloud-based, sustainable digital platform to increase fertility awareness. The platform will provide basic information on fertility preservation methods in plain language to support informed decisions. Content will be based on European Society of Human Reproduction and Embryology (ESHRE) , International Federation of Gynaecology and Obstetrics (FIGO) and Asian Society of Gynecologic Oncology (ASCO) guidelines. The study targets not only cancer patients but also women requesting fertility preservation for medical or social reasons.

In the first stage, the platform will be designed with the ADDIE instructional design model (Analysis, Design, Development, Implementation, Evaluation) and content created per international guidelines. In the second stage, the prototype will be pilot-tested and revised. In the third stage, effectiveness will be tested through a randomized controlled trial. Educational modules will be provided to the intervention group, while the control group will receive brochures. The study will include women aged 18-45 with early-stage gynecological cancer (cervix, ovary, tube, endometrium) at Prof. Dr. Cemil Tascioglu City Hospital, untreated. Participants must have Turkish literacy and internet access. Sample size, calculated with G*Power, is 140 total (70 per group).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Fertility Preservation Gynecologic Cancers

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Biruni University

Istanbul, Zeytinburnu, 34020, Turkey (Türkiye)

About this study

This is a randomized controlled experimental study. The research was carried out in the Prof. Dr. Cemil Tascioglu City Hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women of reproductive age between the ages of 18 and 45,
  • Diagnosed with early stage cervical cancer, ovarian cancer, tubal cancer and endometrial cancer and whose treatment has not started,
  • Those who have a smartphone and can use the platform,
  • Volunteering and giving informed consent,
  • Turkish literate,
  • Individuals who do not report mental problems
  • Do not have children,
  • Marital status is married or single.

Exclusion criteria

  • Neurological disease (e.g., stroke, multiple sclerosis) or cognitive impairment,
  • Advanced-stage gynecologic cancers,
  • Failure to complete the follow-up period,
  • Initiation of oncologic treatment during the study period,
  • Non-completion or incomplete completion of the data collection instruments,
  • Non-use of the platform among participants allocated to the intervention group,
  • History of prior cancer treatment.

Treatment and study plan

Developing a Modular Cloud-Based Platform to guide decision-making in fertility preservation

Other

In this study, a modular cloud-based platform will be developed to raise awareness about fertility preservation.

Primary outcomes

  1. Awareness rates regarding fertility preservation options among patients in the experimental and control groups

    Time frame: Change from beginning of the study and after 3 weeks of after the mobile application is given

    These data will be obtained through the answers given to the "Awareness status questionnaire for fertility protection".

  2. fertility preservation knowledge scores

    Time frame: Change from beginning of the study and after 3 weeks of after the mobile application is given

    The Fertility Health Knowledge Scale was developed to evaluate individuals' level of knowledge about fertility health; The Turkish validity and reliability study of the scale was conducted. In this study, the knowledge level of the participants regarding fertility/fertility preservation will be evaluated based on the knowledge score using the scale in question.

  3. fertility preservation attitude scores

    Time frame: Change from beginning of the study and after 3 weeks of after the mobile application is given

    The Attitudes Toward Fertility and Childbearing Scale was developed to evaluate the attitudes of women who have not yet become mothers towards fertility and childbearing. The Turkish validity and reliability study of the scale was conducted. In this study, participants' attitude scores (sub-dimensions and total attitude level) towards fertility and childbearing will be evaluated using the scale in question.

  4. Acceptance of fertility preservation

    Time frame: Change from beginning of the study and after 3 weeks of after the mobile application is given

    number of patients undergoing fertility preservation procedures

Study contacts

Contact information is provided by the study sponsor or research team.

Huriye Sena Kuruc, MSc

CONTACT

[email protected]

90+ 0531 458 13 13

Nezihe KIZILKAYA BEJI, Professor

CONTACT

[email protected]

90+ 0532 502 34 94

Sponsors and collaborators

Lead sponsor

Biruni University

Other

Collaborators

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Registry information

Official study title

A Modular CLoud Based Platform To Enhance Fertility Preservation Awareness: Design, Pilot Testing And Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jun 11, 2026
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.